Literature DB >> 16329046

RhoB in cancer suppression.

M Huang1, G C Prendergast.   

Abstract

RhoB is a mainly endosomal small GTPase that regulates actin organization and vesicle trafficking. Expression of RhoB is elevated rapidly by many stimuli, including growth factors, cytokines, and genotoxic stress. In cancer, RhoB can limit cell proliferation, survival, invasion, and metastasis, and during malignant progression its levels are attenuated commonly. In support of its role as a negative modifier of cancer progression, targeted deletion of RhoB in mice can increase tumor formation initiated by Ras mutation. How RhoB acts to suppress different aspects of cancer pathophysiology has emerged as a question of significant interest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16329046     DOI: 10.14670/HH-21.213

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  55 in total

1.  NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells.

Authors:  Bo-Kyung Kim; Dong-Myung Kim; Kyung-Sook Chung; Song-Kyu Park; Shin-Jung Choi; Alexander Song; Kiho Lee; Chang-Woo Lee; Kyung-Bin Song; Gyoonhee Han; Julian Simon; Hwan Mook Kim; Misun Won
Journal:  Invest New Drugs       Date:  2010-04-30       Impact factor: 3.850

2.  A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles.

Authors:  Sang-Hyuk Chung; Kristopher K Frese; Robert S Weiss; B V Venkataram Prasad; Ronald T Javier
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

Review 3.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

4.  RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice.

Authors:  Arturo Bravo-Nuevo; Hikaru Sugimoto; Seema Iyer; Zachary Fallon; Jason M Lucas; Shiva Kazerounian; George C Prendergast; Raghu Kalluri; Nathan I Shapiro; Laura E Benjamin
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Authors:  Carolyn D Hurst; Olivia Alder; Fiona M Platt; Alastair Droop; Lucy F Stead; Julie E Burns; George J Burghel; Sunjay Jain; Leszek J Klimczak; Helen Lindsay; Jo-An Roulson; Claire F Taylor; Helene Thygesen; Angus J Cameron; Anne J Ridley; Helen R Mott; Dmitry A Gordenin; Margaret A Knowles
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

6.  miR-23a promotes the transition from indolent to invasive colorectal cancer.

Authors:  Sohail Jahid; Jian Sun; Robert A Edwards; Diana Dizon; Nicole C Panarelli; Jeffrey W Milsom; Shaheen S Sikandar; Zeynep H Gümüs; Steven M Lipkin
Journal:  Cancer Discov       Date:  2012-03-30       Impact factor: 39.397

7.  The interaction of PKN3 with RhoC promotes malignant growth.

Authors:  Keziban Unsal-Kacmaz; Shoba Ragunathan; Edward Rosfjord; Stephen Dann; Erik Upeslacis; Mary Grillo; Richard Hernandez; Fiona Mack; Anke Klippel
Journal:  Mol Oncol       Date:  2011-12-28       Impact factor: 6.603

Review 8.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

9.  RhoB regulates PDGFR-beta trafficking and signaling in vascular smooth muscle cells.

Authors:  Minzhou Huang; James B Duhadaway; George C Prendergast; Lisa D Laury-Kleintop
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-19       Impact factor: 8.311

10.  Rac and Rho GTPases in cancer cell motility control.

Authors:  Matteo Parri; Paola Chiarugi
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.